GR3006256T3 - - Google Patents
Info
- Publication number
- GR3006256T3 GR3006256T3 GR920402597T GR920402597T GR3006256T3 GR 3006256 T3 GR3006256 T3 GR 3006256T3 GR 920402597 T GR920402597 T GR 920402597T GR 920402597 T GR920402597 T GR 920402597T GR 3006256 T3 GR3006256 T3 GR 3006256T3
- Authority
- GR
- Greece
- Prior art keywords
- phthalazin
- fluorobenzyl
- bromo
- oxo
- pharmaceutically acceptable
- Prior art date
Links
- LKBFFDOJUKLQNY-UHFFFAOYSA-N 2-[3-[(4-bromo-2-fluorophenyl)methyl]-4-oxo-1-phthalazinyl]acetic acid Chemical compound O=C1C2=CC=CC=C2C(CC(=O)O)=NN1CC1=CC=C(Br)C=C1F LKBFFDOJUKLQNY-UHFFFAOYSA-N 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229940116269 uric acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Semiconductor Lasers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878704569A GB8704569D0 (en) | 1987-02-26 | 1987-02-26 | Therapeutic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3006256T3 true GR3006256T3 (en:Method) | 1993-06-21 |
Family
ID=10613007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920402597T GR3006256T3 (en:Method) | 1987-02-26 | 1992-11-16 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4895843A (en:Method) |
| EP (1) | EP0296695B1 (en:Method) |
| JP (1) | JPH01216931A (en:Method) |
| KR (1) | KR880009653A (en:Method) |
| AT (1) | ATE81005T1 (en:Method) |
| DE (1) | DE3874978T2 (en:Method) |
| DK (1) | DK169304B1 (en:Method) |
| ES (1) | ES2052701T3 (en:Method) |
| GB (2) | GB8704569D0 (en:Method) |
| GR (1) | GR3006256T3 (en:Method) |
| HU (1) | HU197845B (en:Method) |
| IE (1) | IE61934B1 (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5064830A (en) * | 1990-08-02 | 1991-11-12 | Pfizer Inc. | Lowering of blood uric acid levels |
| CA2685202C (en) | 2007-03-23 | 2017-11-28 | The Board Of Regents Of The University Of Texas System | Methods for treating allergic asthma |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
-
1987
- 1987-02-26 GB GB878704569A patent/GB8704569D0/en active Pending
-
1988
- 1988-02-09 US US07/154,019 patent/US4895843A/en not_active Expired - Fee Related
- 1988-02-18 AT AT88301379T patent/ATE81005T1/de not_active IP Right Cessation
- 1988-02-18 EP EP88301379A patent/EP0296695B1/en not_active Expired - Lifetime
- 1988-02-18 DE DE8888301379T patent/DE3874978T2/de not_active Expired - Fee Related
- 1988-02-18 GB GB8803763A patent/GB2201343B/en not_active Expired - Lifetime
- 1988-02-18 ES ES88301379T patent/ES2052701T3/es not_active Expired - Lifetime
- 1988-02-24 HU HU88872A patent/HU197845B/hu not_active IP Right Cessation
- 1988-02-25 IE IE51588A patent/IE61934B1/en not_active IP Right Cessation
- 1988-02-25 DK DK099488A patent/DK169304B1/da not_active IP Right Cessation
- 1988-02-26 KR KR1019880002083A patent/KR880009653A/ko not_active Ceased
- 1988-02-26 JP JP63044019A patent/JPH01216931A/ja active Pending
-
1992
- 1992-11-16 GR GR920402597T patent/GR3006256T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01216931A (ja) | 1989-08-30 |
| HU197845B (en) | 1989-06-28 |
| US4895843A (en) | 1990-01-23 |
| ATE81005T1 (de) | 1992-10-15 |
| IE880515L (en) | 1988-08-26 |
| EP0296695A3 (en) | 1990-07-18 |
| KR880009653A (ko) | 1988-10-04 |
| DE3874978T2 (de) | 1993-02-18 |
| GB8704569D0 (en) | 1987-04-01 |
| ES2052701T3 (es) | 1994-07-16 |
| GB2201343B (en) | 1990-11-14 |
| IE61934B1 (en) | 1994-11-30 |
| HUT46213A (en) | 1988-10-28 |
| DK99488D0 (da) | 1988-02-25 |
| EP0296695A2 (en) | 1988-12-28 |
| DE3874978D1 (de) | 1992-11-05 |
| DK99488A (da) | 1988-08-27 |
| GB8803763D0 (en) | 1988-03-16 |
| GB2201343A (en) | 1988-09-01 |
| EP0296695B1 (en) | 1992-09-30 |
| DK169304B1 (da) | 1994-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH25458A (en) | Piperidine derivatives, therapeutic, preventive agents | |
| AU2297388A (en) | Therapeutic agents | |
| IT1222395B (it) | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| FI880944L (fi) | Kombinationsterapi varvid man anvaender antitumoer immunotoxiner tillsammans med tumoersnekrosfaktor. | |
| GR3003555T3 (en:Method) | ||
| GB2204239B (en) | Ophthalmic composition. | |
| GB8716975D0 (en) | Therapeutic agents | |
| GB8701392D0 (en) | Therapeutic agents | |
| GB8704569D0 (en) | Therapeutic agent | |
| GB8727792D0 (en) | Therapeutic agents | |
| AU1935988A (en) | Electro-pneumatic device for massages and/or improving the venolymphatic circulation | |
| GR3015185T3 (en) | Herbicidally active phenoxy-alkanecarboxylic acid derivatives. | |
| GB8721343D0 (en) | Therapeutic agents | |
| GB8721342D0 (en) | Therapeutic agents | |
| GB8720939D0 (en) | Therapeutic agents | |
| GB8709842D0 (en) | Therapeutic agents | |
| ZA887262B (en) | Therapeutic agents | |
| GB8715722D0 (en) | Therapeutic agents | |
| GB8720941D0 (en) | Therapeutic agents | |
| GB8727990D0 (en) | Therapeutic agents | |
| GB8729926D0 (en) | Therapeutic agents | |
| GB8729925D0 (en) | Therapeutic agents | |
| IE870521L (en) | Therapeutic agents | |
| IE872942L (en) | Therapeutic agents |